<< back
New wins
We are very proud to have started new relationships with clients who share ROAD’s philosophy of creating advocacy through great content and by building planned relationships.
  ROAD is supporting Wyeth Pharmaceuticals in the expansion of its haemophilia division. The agency is working on a series of medical education and web-based communication tools to support ReFacto – Wyeth’s recombinant Factor VIII clotting agent. Haemophilia is a rare blood condition caused by a deficiency in an essential clotting factor. It is a life-long genetic condition that affects approximately 7,000 people in the UK.
www.haemophilialife.co.uk
ROAD is to support United Therapeutics Europe as its lead creative, marketing and medical education agency in Europe. United Therapeutics’ key product is Remodulin - for the treatment of Pulmonary Arterial Hypertension.
www.unither.com
|
